礼来公开警示替尔泊肽与维生素B12混用存在安全风险

格隆汇
Mar 13

礼来发布公开警示称,替尔泊肽与维生素B12混合使用可能存在安全风险。秉承对患者安全的承诺,其对在美国市场销售、含替尔泊肽与B12(包括甲钴胺、羟钴胺或氰钴胺)复合成分的产品开展了检测。经检测,替尔泊肽与B12发生化学反应,会产生含量显著的未知杂质。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10